| Patents for C07D 413 - Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms (64,687) |
|---|
| 09/13/2007 | US20070213345 Immuno Inhibitory Pyrazolone Compounds |
| 09/13/2007 | US20070213333 Suppress production of both prostaglandins and leukotrienes and have reduced side effects; treatment of various inflammatory diseases, autoimmune diseases, allergic diseases, pain and fibrosis; for example, methyl 3-[3-acetylamino-4-cyclopentyloxy-5-(naphthalen-2-yl)phenyl]propionate |
| 09/13/2007 | US20070213331 Beta -secretase (BACE); Alzheimer's disease; 2-(R)-[2-(S)-Amino-3-(3,5-difluorophenyl)-1-(S)-hydroxypropyl]-pyrrolidine-1-carboxylic acid tert-butyl ester |
| 09/13/2007 | US20070213325 Multi-cyclic compound and method of use |
| 09/13/2007 | US20070213323 Novel pyridinone derivatives and their use as positive allosteric modulators of mglur2-receptors |
| 09/13/2007 | US20070213319 Inflammatory diseases and dysproliferative diseases such as rheumatoid arthritis, cancer; N2-(2-(phenylthiobenzyl)-2,4-diamino-quinazolines |
| 09/13/2007 | US20070213316 N,N'-substituted-1,3-diamino-2-hydroxypropane derivatives |
| 09/13/2007 | US20070213315 Modulators of muscarinic receptors |
| 09/13/2007 | US20070213314 Dibenzyl Amine Compounds and Derivatives |
| 09/13/2007 | CA2644850A1 Quinoline and isoquinoline derivatives as phosphodiesterase 10 inhibitors |
| 09/13/2007 | CA2644280A1 Phosphodiesterase 10 inhibitors |
| 09/13/2007 | CA2642602A1 Substituted arylsulfonamides as antiviral agents |
| 09/12/2007 | EP1832584A1 Pyrimidinylisoxazol derivative |
| 09/12/2007 | EP1831209A2 Cdc25 phosphatase inhibitors |
| 09/12/2007 | EP1831208A1 Quaternary ammonium salts as m3 antagonists |
| 09/12/2007 | EP1831202A1 Pyrrolinidium derivatives as m3 muscarinic receptors |
| 09/12/2007 | EP1831195A1 5-ht7 receptor antagonists |
| 09/12/2007 | EP1831194A1 HETEROCYCLIC MCHr1 ANTAGONISTS AND THEIR USE IN THERAPY |
| 09/12/2007 | EP1831184A2 Pyrazines and pyridines and derivatives thereof as therapeutic compounds |
| 09/12/2007 | EP1831174A1 Amide derivatives |
| 09/12/2007 | EP1831173A1 Tetrahydroisoquinoline compounds for treatment of cns disorders |
| 09/12/2007 | EP1831153A2 Compounds derived from lidocaine, pharmaceutical compositions, use and method of treatment, prevention or inhibition of diseases |
| 09/12/2007 | EP1831145A1 Substituted oxyarenes |
| 09/12/2007 | EP1613304B1 Dpp-iv inhibitors |
| 09/12/2007 | EP1303496B1 Pyrimidine derivatives |
| 09/12/2007 | EP0994867B1 Polymorphic form of the tachykinin receptor antagonist 2-(r)-(1-(r) -(3,5-bis(trifluoromethyl) phenyl)ethoxy)-3-(s)-(4-fluoro) phenyl-4-(3-5 (-oxo-1h,4h-1,2,4,-triazolo) methylmorpholine |
| 09/12/2007 | CN101035784A New bicyclic antibiotics |
| 09/12/2007 | CN101035783A Urea derivatives as calcium channel blockers |
| 09/12/2007 | CN101035782A Mif-inhibitors |
| 09/12/2007 | CN101035781A 2-morpholino-4-pyrimidone compound |
| 09/12/2007 | CN100336813C Oxazoles as mGluR1 enhancer |
| 09/12/2007 | CN100336809C Peptide deformylase inhibitors |
| 09/11/2007 | US7268232 Androgen receptor modulators and method of treating disease using the same |
| 09/11/2007 | US7268149 Cyclothiocarbamate derivatives as progesterone receptor modulators and methods of treating skin disorders |
| 09/11/2007 | US7268143 Isoquinoline derivatives and methods of use thereof |
| 09/11/2007 | US7268140 (2S)-1-((4-chlorophenoxy)methyl)carbonyl-2-methyl-4-(4-fluorobenzyl)piperazine; inhibit the activity of the chemokines, MIP-1 alpha and RANTES |
| 09/11/2007 | US7268134 Medical devices employing triazine compounds and compositions thereof |
| 09/11/2007 | US7268133 Cannabinoid receptor ligands and uses thereof |
| 09/11/2007 | US7268132 Thio substituted with a hetero multiring group; sleepiness, promotion of wakefulness, Parkinson's disease, cerebral ischemia, stroke, sleep apneas, eating disorders, stimulation of appetite and weight gain, attention deficit hyperactivity disorder |
| 09/11/2007 | US7268128 Increase the intracellular cAMP level and further inhibit the activation of T cells; allergic diseases, inflammatory or immunological diseases |
| 09/11/2007 | US7268125 2-(azetidin-2-on-1-yl)alkanedioic acid esters and amides useful for treating disease states that are associated with and responsive to antagonism of a vasopressin V1a receptor in a mammal |
| 09/11/2007 | CA2432064C Novel process for the synthesis of 5-(4-fluorophenyl)-1-[2-((2r,4r)-4-hydroxy-6-oxo-tetrahydro-pyran-2-yl)-ethyl]-2-isopropyl-4-phenyl-1h-pyrrole-3-carboxylic acid phenylamide |
| 09/11/2007 | CA2318368C Novel tricyclic compound |
| 09/11/2007 | CA2176935C Indole-derived azylpiperazines as ligands for 5ht1-like receptors 5ht1b and 5ht1d |
| 09/07/2007 | WO2007101213A2 Novel 2-oxo-1,2,3,4-tetrahydropyrimidines, bicyclic pyrimidine diones and imidazolidine-2,4-diones useful as inducible nitric oxide synthase inhibitors |
| 09/07/2007 | WO2007100880A1 Cinnoline and quinazoline derivates as phosphodiesterase 10 inhibitors |
| 09/07/2007 | WO2007100646A1 Multi-cyclic compounds and method of use |
| 09/07/2007 | WO2007100295A1 Novel dual action receptors antagonists (dara) at the ati and eta receptors |
| 09/07/2007 | WO2007100066A1 17β HSD type 5 INHIBITOR |
| 09/07/2007 | WO2007099828A1 Nirogenous heterocyclic derivatives substituted with cyclic groups |
| 09/07/2007 | WO2007039177A3 Phenyl- and pyridinyl- 1, 2 , 4 - oxadiazolone derivatives, processes for their preparation and their use as pharmaceuticals |
| 09/07/2007 | WO2007011878A3 Beta-lactamyl phenylalanine, cysteine, and serine vasopressin antagonists |
| 09/07/2007 | CA2644809A1 17 .beta. hsd type 5 inhibitor |
| 09/07/2007 | CA2644578A1 Novel dual action receptors antagonists (dara) at the ati and eta receptors |
| 09/07/2007 | CA2643044A1 Cinnoline and quinazoline derivates as phosphodiesterase 10 inhibitors |
| 09/06/2007 | US20070208185 Intermediates for the hemisynthesis of taxanes and preparation processes therefor |
| 09/06/2007 | US20070208070 2-thioxo-4-imidazolines; angina, hypertension, congestive heart failure, myocardial ischemia, arrhythmia, diabetes, urinary incontinence, stroke, pain, brain injury, or neuronal disorders |
| 09/06/2007 | US20070208069 Pharmaceutical formulations of an anhydrous crystal form of 2-(3-fluoro-4-hydroxyphenyl)-7-vinyl-1,3-benzoxazol-5-ol |
| 09/06/2007 | US20070208066 ER-beta-selective ligands |
| 09/06/2007 | US20070208064 Ion channel modulators |
| 09/06/2007 | US20070208062 3-(4-(2-dihydroisoxazol-3-ylpyridin-5-yl)phenyl)-5-triazol-1-ylmethyloxazolidin-2-one derivatives as mao inhibitors for the treatment of bacterial infections |
| 09/06/2007 | US20070208049 e.g. 1-(2,6-Difluorobenzyl)-5-(3-Mehthoxyphenyl)-6-Methyl-3-[N-Methyl -N -(2-Pyridylethyl)Aminoethyl]Uracil; anticarcinoganic agent; prostate cancer, benign prostatic hypertrophy, breast cancer and endometriosis |
| 09/06/2007 | US20070208048 New Aryl Imidazoles and Related Compounds as C5a Receptor Modulators |
| 09/06/2007 | US20070208026 N-Containing Heteroaromatic Compounds As Modulators Of Ppars And Methods Of Treating Metabolic Disorders |
| 09/06/2007 | US20070208024 (3-Fluoro-4'-methanesulfonyl-biphenyl-4-yl)-[2-(S)-(2-(R)-methyl-pyrrolidin-1-ylmethyl)-pyrrolidin-1-yl]-methanone; treatment of obesity, cognitive deficiencies, narcolepsy, and other histamine H3 receptor-related diseases |
| 09/06/2007 | US20070208022 Hiv inhibiting 5-carbo- or heterocyclyl substituted pyrimidines |
| 09/06/2007 | US20070208021 Phenoxyacetic Acid Derivatives and Drug Comprising The Same |
| 09/06/2007 | US20070208020 P70S6 Kinase Modulators And Method Of Use |
| 09/06/2007 | US20070208018 Quinazoline Derivatives |
| 09/06/2007 | US20070208017 e.g. 3-(3-{[7-({(2R)-2-hydroxy-2-[4-hydroxy-3-(hydroxymethyl)phenyl]ethyl}-amino)heptyl]oxy}propyl)benzenesulfonamide triphenylacetate; beta 2-adrenoreceptors stimulant, bronchodilator; reversible airways obstruction: asthma, chronic obstructive pulmonary disease (COPD), respiratory tract infection |
| 09/06/2007 | US20070208015 5-Morpholinylmethylthiophenyl Pharmaceutical Compounds As P38 MAP Kinase Modulators |
| 09/06/2007 | US20070208014 Novel 2-substituted benzimidazoles as selective androgen receptor modulators (sarms) |
| 09/06/2007 | US20070208012 Modulation of Pathogenicity |
| 09/06/2007 | US20070208007 Amine-Based Compound and Use Thereof |
| 09/06/2007 | US20070208005 Tetrahydrobenzazepines as antagonists and/or reverse agonists of the histamine h3 receptor |
| 09/06/2007 | US20070207999 New Compounds |
| 09/06/2007 | US20070207994 3-Phenyl-pyrazole derivatives as modulators of the 5-HT2a serotonin receptor useful for the treatment of disorders related thereto |
| 09/06/2007 | US20070207991 Substituted N-aryl Heterocycles, Process For Their Preparation and Their Use As Medicaments |
| 09/06/2007 | US20070207985 treating diabetes, hyperglycemia, obesity, dyslipidemia, and hypertension; compounds are based on 1,2,4-triazine and fused ring derivatives thereof, for example 3-Adamantan-1-yl-5,6-dimethyl-1,2,4-triazine |
| 09/05/2007 | EP1828177A2 Novel mch receptor antagonists |
| 09/05/2007 | EP1828176A1 Tetrahydroquinoline analogues as muscarinic agonists |
| 09/05/2007 | EP1828169A2 Urea inhibitors of map kinases |
| 09/05/2007 | EP1828145A2 2' and 3' - substituted cyclobutyl nucleoside analogs for the treatment of viral infections and abnormal cellular proliferation |
| 09/05/2007 | EP1828144A2 Integrin antagonists useful as anticancer agents |
| 09/05/2007 | EP1828127A2 INSECTICIDAL BIS(SUBSTITUTED PHENYL)-1-äÝ4-(SATURATED HETEROCYCLYL-SUBSTITUTED)PHENYLMETHYL¨-(4-PIPERIDYL)üMETHANE DERIVATIVES |
| 09/05/2007 | EP1828123A1 Indolinones and their use as antiproliferative agents |
| 09/05/2007 | EP1827427A1 Aryloxyethylamine derivatives with a combination of partial dopamine-d2 receptor agonism and serotonin reuptake inhibition |
| 09/05/2007 | EP1827426A1 Phenylpiperazine derivatives with a combination of partial dopamine-d2 receptor agonism and serotonin reuptake inhibition |
| 09/05/2007 | EP1373233B1 Derivatives of n-(arylsulfonyl)beta-aminoacids comprising a substituted aminomethyl group, the preparation method thereof and the pharmaceutical compositions containing same |
| 09/05/2007 | CN101031567A Novel piperidin-4-yl-thiazole-carboxamide analogues as inhibitors of t-cell proliferation and uses thereof |
| 09/05/2007 | CN101031566A Proline derivatives |
| 09/05/2007 | CN101031565A Substituted 2h-1,3-benzoxazin-4(3h)-ones |
| 09/05/2007 | CN101031561A Carbonyl compounds used as coagulation factor xa inhibitor |
| 09/05/2007 | CN101031560A Cyclic diaryl ureas suitable as tyrosine kinase inhibitors |
| 09/05/2007 | CN101031558A HIV inhibiting 5-heterocyclyl pyrimidines |
| 09/05/2007 | CN101031554A Benzoxazine and quinoxaline derivatives and uses |
| 09/05/2007 | CN101031552A Photoactive 4,4-disubstituted oxazolidine derivative and its manufacturing method |
| 09/05/2007 | CN101031550A HIV inhibiting 5-carbo- or heterocyclic substituted pyrimidines |
| 09/05/2007 | CN101031545A Isoindoline compounds and methods of their use |
| 09/05/2007 | CN101031539A Substituted arylalkanoic acid derivatives and use thereof |